Shattuck Labs names Shoba Ravichandran senior vice president, clinical development
STTK•Shattuck Labs named Shoba Ravichandran senior vice president of clinical development to lead its SL-325 hidradenitis suppurativa program. She previously spent more than a decade at Novartis and led Cosentyx’s global approval in the disease.
1. Clinical development leadership
Ravichandran most recently served as senior global program clinical head at Novartis. She also led Phase 3 start-up for remibrutinib in hidradenitis suppurativa.
